
Acuitas Therapeutics Demonstrates Enhanced mRNA-LNP Activity in Cancer and Viral Vaccine Development
Acuitas Therapeutics Demonstrates Enhanced mRNA-LNP Activity in Cancer and Viral Vaccine Development Vancouver, BC, May 9, 2025--(T-Net)--Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems, shared key findings from its latest mRNA- …